Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
922
datasets available to search
ShareScore release 0.9.0
Dataset results
922 results for “Chronic lymphocytic leukemia”
A Study of ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00481091. IPD Sharing: YES. Countries: 4. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
ClinicalTrials.gov study NCT00774345. IPD Sharing: Not stated. Countries: 25. Publications: 1.
Ibrutinib in Combination With GA101 (Obinutuzumab) in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients.
ClinicalTrials.gov study NCT02315768. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of the Efficacy of ABT-199 in Subjects With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia With the 17p Deletion
ClinicalTrials.gov study NCT01889186. IPD Sharing: YES. Countries: 7. Publications: 4.
Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte Leukemia
ClinicalTrials.gov study NCT03759184. IPD Sharing: YES. Countries: 1. Publications: 2.
Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00425802. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Idelalisib in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01659021. IPD Sharing: YES. Countries: 11. Publications: 2.
Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT01724346. IPD Sharing: YES. Countries: 16. Publications: 5.
PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia
ClinicalTrials.gov study NCT01589302. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lym
ClinicalTrials.gov study NCT00104858. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01539512. IPD Sharing: YES. Countries: 5. Publications: 3.
Nivolumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or High-Risk Untreated Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Richter Transformation
ClinicalTrials.gov study NCT02420912. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ofatumumab and Bendamustine for Previously Treated Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01010568. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Obinutuzumab + Bendamustine (BG) in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT02320487. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pentostatin, Alemtuzumab, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT00669318. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00096018. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Participants With High Risk Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT02477696. IPD Sharing: YES. Countries: 15. Publications: 6.
A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02251548. IPD Sharing: NO. Countries: 1. Publications: 2.
A Study of Different Doses of Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT02801578. IPD Sharing: Not stated. Countries: 1. Publications: 1.
HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I)
ClinicalTrials.gov study NCT03685708. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.